1. PRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry. Issue 10 (13th November 2018) Authors: Jones, Gemma; Rooney, Claire; Griffin, Nicola; Roudier, Martine; Young, Lucy A.; Garcia-Trinidad, Antonio; Hughes, Gareth; Whiteaker, Jeffrey; Wilson, Zena; Odedra, Rajesh; Zhao, Lei; Ivey, Richard; Howat, William; Harrington, Elizabeth; Barrett, J.; Ramos-Montoya, Antonio; Lau, Alan; Paulovich, ... Journal: British journal of cancer Issue: Volume 119:Issue 10(2018) Page Start: 1233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗